Figshareopen access

Cost‑effectiveness of first‑line immunotherapy-based combination regimens for advanced renal cell carcinoma in China and the United States

Name: Cost‑effectiveness of first‑line immunotherapy-based combination regimens for advanced renal cell carcinoma in China and the United States
License: Open Access

Chunyan Yan (12001980) et al.

Figshare · Datasets · License: Open Access

Open Source ↗

cancer medicine

medicine, pharmacology, sociology, marine biology, cancer, science policy, plant biology, computational biology

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Cost‑effectiveness of first‑line immunotherapy-based combination regimens for advanced renal cell carcinoma in China and the United States

Related documents